Endocrinology, Vol 135, 929-937, Copyright © 1994 by Endocrine Society

ARTICLES

Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets

MA Thiede, SL Smock, DN Petersen, WA Grasser, DD Thompson and SK Nishimoto
Department of Cardiovascular and Metabolic Diseases, Pfizer, Inc., Groton, Connecticut 06340.

Osteocalcin (Oc), an abundant gamma-carboxylated protein (mol wt, 5800) of bone matrix, is used as a serum marker of bone turnover because it is considered to be uniquely synthesized by the osteoblast. Our finding of Oc messenger RNA (mRNA) in rat tibial diaphyseal marrow led us to investigate the cellular origins of Oc mRNA in peripheral blood and bone marrow. In anticoagulated blood, Oc mRNA was detected in total RNA prepared from buffy coat cells (BCC). Fractionation of rat and human blood showed that platelets contain Oc mRNA identical to that found in bone cells. In rat bone marrow, Oc mRNA is highly enriched in the platelet-producing megakaryocyte population. Depending upon the RIA used, immunoreactive Oc was either undetectable or present at very low levels in platelets and megakaryocytes, suggesting that synthesis of Oc by these cells may be under strong translational regulation. In addition, Oc levels were higher in serum vs. plasma obtained from the same blood, suggesting that Oc may be released by platelets during blood clotting. Interestingly, the magnitude of this difference was greater in female rats. Injection of 1,25-dihydroxyvitamin D3 dose- dependently increased plasma Oc, but did not cause correlative changes in steady state levels of Oc mRNA in BCC. During rat growth, plasma Oc was maximal, whereas Oc mRNA levels in BBC were low. This relationship was reversed during aging. A correlation between Oc mRNA levels in BCC and rat age suggests a developmental regulation of Oc mRNA levels in platelets. These data indicate that Oc mRNA is not restricted to cells on mineralizing surfaces, but is also found in megakaryocytes and peripheral blood platelets, which possibly contribute to the Oc levels in blood and the regulation of bone turnover.

This article has been cited by other articles:

				R. Garimella, M. A. Kacena, S. E. Tague, J. Wang, M. C. Horowitz, and H. C. Anderson Expression of Bone Morphogenetic Proteins and Their Receptors in the Bone Marrow Megakaryocytes of GATA-1low Mice: A Possible Role in Osteosclerosis J. Histochem. Cytochem., July 1, 2007; 55(7): 745 - 752. [Abstract] [Full Text] [PDF]

				S. KHOSLA and G. Z. EGHBALI-FATOURECHI Circulating Cells with Osteogenic Potential Ann. N.Y. Acad. Sci., April 1, 2006; 1068(1): 489 - 497. [Abstract] [Full Text] [PDF]

				F. H. Chen, C. JX. Lee, and J. E. Aubin Osteoblasts May Take a Road Well-Traveled IBMS BoneKEy, September 1, 2005; 2(9): 14 - 18. [Full Text] [PDF]

				G. Z. Eghbali-Fatourechi, J. Lamsam, D. Fraser, D. Nagel, B. L. Riggs, and S. Khosla Circulating Osteoblast-Lineage Cells in Humans N. Engl. J. Med., May 12, 2005; 352(19): 1959 - 1966. [Abstract] [Full Text] [PDF]

				K. K. Ivaska, T. A. Hentunen, J. Vaaraniemi, H. Ylipahkala, K. Pettersson, and H. K. Vaananen Release of Intact and Fragmented Osteocalcin Molecules from Bone Matrix during Bone Resorption in Vitro J. Biol. Chem., April 30, 2004; 279(18): 18361 - 18369. [Abstract] [Full Text] [PDF]

				W. S. Browner, L.-Y. Lui, and S. R. Cummings Associations of Serum Osteoprotegerin Levels with Diabetes, Stroke, Bone Density, Fractures, and Mortality in Elderly Women J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 631 - 637. [Abstract] [Full Text]

				A. Yamaguchi, T. Komori, and T. Suda Regulation of Osteoblast Differentiation Mediated by Bone Morphogenetic Proteins, Hedgehogs, and Cbfa1 Endocr. Rev., August 1, 2000; 21(4): 393 - 411. [Abstract] [Full Text] [PDF]

				G. Zhao, M.-C. Monier-Faugere, M. C. Langub, Z. Geng, T. Nakayama, J. W. Pike, S. D. Chernausek, C. J. Rosen, L.-R. Donahue, H. H. Malluche, et al. Targeted Overexpression of Insulin-Like Growth Factor I to Osteoblasts of Transgenic Mice: Increased Trabecular Bone Volume without Increased Osteoblast Proliferation Endocrinology, July 1, 2000; 141(7): 2674 - 2682. [Abstract] [Full Text] [PDF]

				I. H. N. Wong, A. T. Chan, and P. J. Johnson Quantitative Analysis of Circulating Tumor Cells in Peripheral Blood of Osteosarcoma Patients Using Osteoblast-specific Messenger RNA Markers: A Pilot Study Clin. Cancer Res., June 1, 2000; 6(6): 2183 - 2188. [Abstract] [Full Text]

				S.-M. Kakonen, J. Hellman, M. Karp, P. Laaksonen, K. J. Obrant, H. K. Vaananen, T. Lovgren, and K. Pettersson Development and Evaluation of Three Immunofluorometric Assays That Measure Different Forms of Osteocalcin in Serum Clin. Chem., March 1, 2000; 46(3): 332 - 337. [Abstract] [Full Text] [PDF]

				A. Bini, K. G. Mann, B. J. Kudryk, and F. J. Schoen Noncollagenous Bone Matrix Proteins, Calcification, and Thrombosis in Carotid Artery Atherosclerosis Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1852 - 1861. [Abstract] [Full Text] [PDF]

				E. Luegmayr, F. Varga, H. Glantschnig, N. Fratzl–Zelman, M. Rumpler, A. Ellinger, and K. Klaushofer 1,25-Dihydroxy Vitamin D3 and Tri-iodothyronine Stimulate the Expression of a Protein Immunologically Related to Osteocalcin J. Histochem. Cytochem., April 1, 1998; 46(4): 477 - 486. [Abstract] [Full Text]

				A. Caillot-Augusseau, M.-H. Lafage-Proust, C. Soler, J. Pernod, F. Dubois, and C. Alexandre Bone formation and resorption biological markers in cosmonauts during and after a 180-day space flight (Euromir 95) Clin. Chem., March 1, 1998; 44(3): 578 - 585. [Abstract] [Full Text] [PDF]

				N. A. Sims, C. P. White, K. L. Sunn, G. P. Thomas, M. L. Drummond, N. A. Morrison, J. A. Eisman, and E. M. Gardiner Human and Murine Osteocalcin Gene Expression: Conserved Tissue Restricted Expression and Divergent Responses to 1,25-Dihydroxyvitamin D3 in Vivo Mol. Endocrinol., October 1, 1997; 11(11): 1695 - 1708. [Abstract] [Full Text]

				T. Wakikawa, A. Shioi, M. Hino, M. Inaba, Y. Nishizawa, N. Tatsumi, H. Morii, and S. Otani Thrombopoietin Inhibits in Vitro Osteoclastogenesis from Murine Bone Marrow Cells Endocrinology, October 1, 1997; 138(10): 4160 - 4166. [Abstract] [Full Text] [PDF]

				E. R. Mohler III, L. P. Adam, P. McClelland, L. Graham, and D. R. Hathaway Detection of Osteopontin in Calcified Human Aortic Valves Arterioscler. Thromb. Vasc. Biol., March 1, 1997; 17(3): 547 - 552. [Abstract] [Full Text]

				D. N. Petersen, G. T. Tkalcevic, A. L. Mansolf, R. Rivera-Gonzalez, and T. A. Brown Identification of Osteoblast/Osteocyte Factor 45 (OF45), a Bone-specific cDNA Encoding an RGD-containing Protein That Is Highly Expressed in Osteoblasts and Osteocytes J. Biol. Chem., November 10, 2000; 275(46): 36172 - 36180. [Abstract] [Full Text] [PDF]